Versant Ventures IV, LLC
- SEC CIK
- 0001456589
Latest role at each company
- TPST Tempest Therapeutics, Inc.10% Owneras of Aug 12, 2024
- CTNM Contineum Therapeutics, Inc.10% Owneras of Apr 11, 2024
- CIK 000172072510% Owneras of Jan 4, 2023
Trades
Every Form 4 that lists Versant Ventures IV, LLC as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| TPSTTempest Therapeutics, Inc. | Aug 12, 20248:33 PM ET | Aug 8 – Aug 12, 2024 | Versant Ventures IV, LLC and 8 others10% Owner | SSaleCommon Stock | −788K | $1.2272 | −$967.03K | 209.94K | −79.0% | SEC |
| – | Oct 20, 20214:38 PM ET | Oct 18, 2021 | Versant Ventures IV, LLC and 8 others10% Owner | SSaleCommon Stock | −550K | $14.8377 | −$8.16M | 4.99K | −99.1% | SEC |